Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Myelodysplastic Syndromes 97Leukemia 94Leukemia, Myeloid, Acute 85Precursor Cell Lymphoblastic Leukemia-Lymphoma 71Lymphoma 65Leukemia, Lymphocytic, Chronic, B-Cell 61Lymphoma, Non-Hodgkin 56Multiple Myeloma 55Hodgkin Disease 51Leukemia, Myeloid, Chronic-Phase 48Myeloproliferative Disorders 47Leukemia, Myeloid, Accelerated Phase 45Lymphoma, Follicular 43Lymphoma, Mantle-Cell 42Lymphoma, Large B-Cell, Diffuse 42Lymphoma, B-Cell, Marginal Zone 41Congenital Abnormalities 40Burkitt Lymphoma 40Neoplasms, Plasma Cell 38Lymphoma, Large-Cell, Immunoblastic 35Graft vs Host Disease 32Blast Crisis 32Leukemia, Myelomonocytic, Chronic 30Primary Myelofibrosis 29Anemia, Refractory, with Excess of Blasts 29Dendritic Cell Sarcoma, Interdigitating 28Recurrence 27Myelodysplastic-Myeloproliferative Diseases 26Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 25Leukemia, Myelogenous, Chronic, BCR-ABL Positive 24

Interventions

Amifostine 19Cisplatin 15Radiotherapy 13Etoposide 10Cyclophosphamide 9Carboplatin 8Paclitaxel 7Filgrastim 7Drug Therapy 5Cytarabine 5apatinib 4sodium thiosulfate 3Methylprednisolone 3Methotrexate 3Gemcitabine 3Docetaxel 3sargramostim 2pegfilgrastim 2etoposide phosphate 2camrelizumab 2Vincristine 2Pyridoxine 2Peripheral Blood Stem Cell Transplantation 2Nivolumab 2Mitoxantrone 2Melphalan 2Irinotecan 2Ifosfamide 2Fibroblast Growth Factor 7 2Epoetin Alfa 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Drug-Related Side Effects and Adverse Reactions × Antilymphocyte Serum × Clear all
NCT00317798 2011-08-30

Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma

University of Rochester

Phase 1 Completed
18 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡